
Inmode Ltd (INMD) Stock Forecast & Price Target
Inmode Ltd (INMD) Analyst Ratings
Bulls say
InMode Ltd experienced a notable increase in its global installed base, with sales of 971 systems in 2Q25, bringing the total to approximately 28,855 units, indicating a 3.4% growth from the previous quarter. The company reported an operating margin of 27.5%, exceeding expectations and reflecting a year-over-year improvement of 40 basis points. Additionally, domestic sales reached $49.7 million, demonstrating a significant turnaround with a growth rate of 9%, compared to a decline of 7% in the prior quarter, underscoring the robust demand in the aesthetics market.
Bears say
InMode Ltd is anticipated to experience a contraction in its margins, despite currently holding among the highest margins in the med tech sector, which could lead to its earnings per share (EPS) growth lagging behind revenue growth. The company's bearish outlook includes expectations of a revenue compound annual growth rate (CAGR) of less than 5% over the next few years, driven by weaker growth from existing products and slower than anticipated adoption of new offerings. Additionally, while operating margins have improved year-over-year, gross margins have decreased, indicating potential pressure on profitability moving forward.
This aggregate rating is based on analysts' research of Inmode Ltd and is not a guaranteed prediction by Public.com or investment advice.
Inmode Ltd (INMD) Analyst Forecast & Price Prediction
Start investing in Inmode Ltd (INMD)
Order type
Buy in
Order amount
Est. shares
0 shares